Functional Living Skills in Patients with Major Neurocognitive Disorder Due to Degenerative or Non-Degenerative Conditions: Effectiveness of a Non-Immersive Virtual Reality Training
Abstract
:1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Description of the System and Apps
- Information: 30 questions about personal, general, family, and spatiotemporal information appear on the screen in verbal and written form simultaneously; the patient is asked to choose the answer from a multiple-choice menu by touching one of the options on the screen.
- Medicines: The task requires the patient to indicate the time of the day at which to take five different types of drugs. In each session, 10 verbal requests are randomly made, and the patient has to touch one of the five medicine boxes on the screen. A visual reminder is always available.
- Suitcase: 10 items (clothing and accessories) must be packed in a suitcase for a weekend out. The task ends with the closing of the suitcase. There are two versions of the app—one for women and one for men.
- Supermarket: The activity requires the purchase of 5 items, presented in a shopping list that remains available upon request. The shopping list changes randomly in different sessions. In the first scene, representing a kitchen, the patient takes the shopping list and the wallet with money; in the second scene, they take the products from the supermarket shelf and put them in the cart; in the third scene, at the checkout, they put the products on the conveyor belt, pay, and exit the shop.
2.3. Procedures
- Pre-treatment assessment (T1): In the pre-treatment phase, all of the patients (M-NCD due to DC or NDC in both EG and CG) were assessed by means of a comprehensive neuropsychological battery, administered by a clinical psychologist who was blinded to the aims of the study, in order to evaluate global mental functioning, executive functioning, memory, and daily living activities. The battery included the MMSE [30], Raven’s Colored Progressive Matrices [37], digit and visuospatial span [38], Rey’s 15 words—immediate and delayed recall— [39], Frontal Assessment Battery [40], activities of daily living [41], and IADL [31]. Table 1 shows the median scores obtained in the neuropsychological battery by the groups. Then, the first in vivo tests were administered in real environments arranged in our institute, in order to evaluate how patients performed the four FLSs (to give information, to take medicines, to prepare a suitcase, and to shop at a supermarket) in a natural setting. The in vivo tests were administered by a behavioral psychologist, using a task analysis form for each activity. The behavioral psychologist did not know the groups to which the different participants had been assigned. No clues or reinforcement were provided, and the number of correct responses and total execution times were recorded. Finally, a digital literacy questionnaire was administered to the EG participants. Table 1 shows the median scores obtained on the in vivo tests by both the EG and CG, along with the median number of technological devices used by the EG participants.
- Treatment (T2): At T2, both EG-DC and EG-NDC were administered the VRT, with five sessions per week over a period of two weeks. We chose to provide only 10 sessions, based on the results of our previous study [29] in which the most significant results were obtained between the 7th and 10th sessions. VRT was added to the usual cognitive stimulation carried out in the neurorehabilitation department of our institute [2]. As stated above, before VRT, two or three test sessions were conducted for familiarization with the touchscreen and the dragging movement. The test app only involved moving a ball from one point on the screen to another. During the VRT, the patients were required to independently manage their device and tasks; nevertheless, the psychologist was always present in the room for general monitoring of the session’s progress and could intervene in case of system malfunction. The variable scores were automatically saved on the server, namely, total execution time, number of correct responses, number of errors, number of missing responses (i.e., participants not answering within 10 s), and number of clues provided to obtain the response. A video demo is available in the Supplementary Materials (Supplementary Video S1).
- Post-treatment assessment (T3): At T3, a second administration of the in vivo test was repeated for the EG (both DC and NDC) and the CG (both DC and NDC). A satisfaction questionnaire arranged in our institute was administered only to the participants who performed the VRT. It included 14 questions: part I (8 questions) focused on the system usability and satisfaction, while part II (6 questions) focused on the technological problems and the negative feelings and symptoms. Single scores ranged from 0 = low to 2 = high. Part I total scores ranging from 0 to 4 were considered to indicate low satisfaction; scores from 5 to 8 indicated low-to-moderate satisfaction; scores from 9 to 12 indicated moderate-to-high satisfaction; and scores from 13 to 16 indicated high satisfaction. Part II total scores ranging from 0 to 3 indicated a low level of problems; scores from 4 to 6 indicated low-to-moderate problems; scores from 7 to 9 indicated moderate-to-high problems; and scores from 10 to 12 indicated a high level of problems.
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Publishing: Arlington, VA, USA, 2013. [Google Scholar]
- Panerai, S.; Tasca, D.; Musso, S.; Catania, V.; Ruggeri, F.; Raggi, A.; Muratore, S.; Prestianni, G.; Bonforte, C.; Ferri, R. Group Intensive Cognitive Activation in Patients with Major or Mild Neurocognitive Disorder. Front. Behav. Neurosci. 2016, 10, 34. [Google Scholar] [CrossRef] [PubMed]
- Nygaard, H.A.; Albrektsen, G. Risk factors for admission to a nursing home. A study of elderly people receiving home nursing. Scand. J. Prim. Health Care 1992, 10, 128–133. [Google Scholar] [CrossRef] [PubMed]
- Gale, S.A.; Acar, D.; Daffner, K.R. Dementia. Am. J. Med. 2018, 131, 1161–1169. [Google Scholar] [CrossRef] [PubMed]
- D’Cunha, N.M.; Nguyen, D.; Naumovski, N.; McKune, A.J.; Kellett, J.; Georgousopoulou, E.N.; Frost, J.; Isbel, S. A mini-review of virtual reality-based interventions to promote well-being for people living with dementia and mild cognitive impairment. Gerontology 2019, 65, 430–440. [Google Scholar] [CrossRef]
- Meyer, C.; O’Keefe, F. Non-pharmacological interventions for people with dementia: A review of reviews. Dementia 2020, 19, 1927–1954. [Google Scholar] [CrossRef]
- Berg-Weger, M.; Stewart, D.B. Non-Pharmacologic Interventions for Persons with Dementia. Mo. Med. 2017, 114, 116–119. [Google Scholar]
- Cipresso, P.; Giglioli, I.A.C.; Raya, M.A.; Riva, G. The Past, Present, and Future of Virtual and Augmented Reality Research: A Network and Cluster Analysis of the Literature. Front. Psychol. 2018, 9, 2086. [Google Scholar] [CrossRef]
- Parsons, T.D.; Gaggioli, A.; Riva, G. Extended reality for the clinical, affective, and social neurosciences. Brain Sci. 2020, 10, 922. [Google Scholar] [CrossRef]
- Kim, E.; Han, J.; Choi, H.; Prié, Y.; Vigier, T.; Bulteau, S.; Kwon, G.H. Examining the Academic Trends in Neuropsychological Tests for Executive Functions Using Virtual Reality: Systematic Literature Review. JMIR Serious Games 2021, 9, e30249. [Google Scholar] [CrossRef]
- Tomaszewski Farias, S.; Cahn-Weiner, D.A.; Harvey, D.J.; Reed, B.R.; Mungas, D.; Kramer, J.H.; Chui, H. Longitudinal changes in memory and executive functioning are associated with longitudinal change in instrumental activities of daily living in older adults. Clin. Neuropsychol. 2009, 23, 446–461. [Google Scholar] [CrossRef]
- Wen, D.; Lan, X.; Zhou, Y.; Li, G.; Hsu, S.H.; Jung, T.P. The Study of Evaluation and Rehabilitation of Patients With Different Cognitive Impairment Phases Based on Virtual Reality and EEG. Front. Aging Neurosci. 2018, 10, 88. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhu, S.; Sui, Y.; Shen, Y.; Zhu, Y.; Ali, N.; Guo, C.; Wang, T. Effects of Virtual Reality Intervention on Cognition and Motor Function in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis. Front. Aging Neurosci. 2021, 13, 586999. [Google Scholar] [CrossRef] [PubMed]
- Plechatá, A.; Sahula, V.; Fayette, D.; Fajnerová, I. Age-Related Differences With Immersive and Non-immersive Virtual Reality in Memory Assessment. Front. Psychol. 2019, 10, 1330. [Google Scholar] [CrossRef] [PubMed]
- Pazzaglia, C.; Imbimbo, I.; Tranchita, E.; Minganti, C.; Ricciardi, D.; Lo Monaco, R.; Parisi, A.; Padua, L. Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson’s disease: A randomised controlled trial. Physiotherapy 2020, 106, 36–42. [Google Scholar] [CrossRef] [PubMed]
- Bevilacqua, R.; Maranesi, E.; Riccardi, G.R.; Di Donna, V.; Pelliccioni, P.; Luzi, R.; Lattanzio, F.; Pelliccioni, G. Non-Immersive Virtual Reality for Rehabilitation of the Older People: A Systematic Review into Efficacy and Effectiveness. J. Clin. Med. 2019, 8, 1882. [Google Scholar] [CrossRef]
- García-López, H.; Obrero-Gaitán, E.; Castro-Sánchez, A.M.; Lara-Palomo, I.C.; Nieto-Escamez, F.A.; Cortés-Pérez, I. Non-Immersive Virtual Reality to Improve Balance and Reduce Risk of Falls in People Diagnosed with Parkinson’s Disease: A Systematic Review. Brain Sci. 2021, 11, 1435. [Google Scholar] [CrossRef]
- Maranesi, E.; Casoni, E.; Baldoni, R.; Barboni, I.; Rinaldi, N.; Tramontana, B.; Amabili, G.; Benadduci, M.; Barbarossa, F.; Luzi, R.; et al. The Effect of Non-Immersive Virtual Reality Exergames versus Traditional Physiotherapy in Parkinson’s Disease Older Patients: Preliminary Results from a Randomized-Controlled Trial. Int. J. Environ. Res. Public Health 2022, 19, 14818. [Google Scholar] [CrossRef]
- Hall, J.R.; Vo, H.T.; Johnson, L.A.; Barber, R.C.; O’Bryant, S.E. The Link between Cognitive Measures and ADLs and IADL Functioning in Mild Alzheimer’s: What Has Gender Got to Do with It? Int. J. Alzheimers Dis. 2011, 2011, 276734. [Google Scholar] [CrossRef]
- Dockx, K.; Bekkers, E.M.; Van den Bergh, V.; Ginis, P.; Rochester, L.; Hausdorff, J.M.; Mirelman, A.; Nieuwboer, A. Virtual reality for rehabilitation in Parkinson’s disease. Cochrane Database Syst. Rev. 2016, 12, CD010760. [Google Scholar] [CrossRef]
- Triegaardt, J.; Han, T.S.; Sada, C.; Sharma, S.; Sharma, P. The role of virtual reality on outcomes in rehabilitation of Parkinson’s disease: Meta-analysis and systematic review in 1031 participants. Neurol. Sci. 2020, 41, 529–536. [Google Scholar] [CrossRef] [PubMed]
- Hofmann, M.; Rösler, A.; Schwarz, W.; Müller-Spahn, F.; Kräuchi, K.; Hock, C.; Seifritz, E. Interactive computer-training as a therapeutic tool in Alzheimer’s disease. Compr. Psychiatry 2003, 44, 213–219. [Google Scholar] [CrossRef] [PubMed]
- Van Schaik, P.; Martyr, A.; Blackman, T.; Robinson, J. Involving persons with dementia in the evaluation of outdoor environments. Cyberpsychology Behav. Impact Internet Multimed. Virtual Real. Behav. Soc. 2008, 11, 415–424. [Google Scholar] [CrossRef] [PubMed]
- Yamaguchi, T.; Foloppe, D.A.; Richard, P.; Richard, E.; Allain, P. A Dual-Modal Virtual Reality Kitchen for (Re)Learning of Everyday Cooking Activities in Alzheimer’s Disease. Presence 2012, 21, 43–57. [Google Scholar] [CrossRef]
- Allain, P.; Foloppe, D.A.; Besnard, J.; Yamaguchi, T.; Etcharry-Bouyx, F.; Le Gall, D.; Nolin, P.; Richard, P. Detecting everyday action deficits in Alzheimer’s disease using a nonimmersive virtual reality kitchen. J. Int. Neuropsychol. Soc. JINS 2014, 20, 468–477. [Google Scholar] [CrossRef]
- Manera, V.; Petit, P.D.; Derreumaux, A.; Orvieto, I.; Romagnoli, M.; Lyttle, G.; David, R.; Robert, P.H. ‘Kitchen and cooking’, a serious game for mild cognitive impairment and Alzheimer’s disease: A pilot study. Front. Aging Neurosci. 2015, 7, 24. [Google Scholar] [CrossRef]
- Fasilis, T.; Patrikelis, P.; Siatouni, A.; Alexoudi, A.; Veretzioti, A.; Zachou, L.; Gatzonis, S.S. A pilot study and brief overview of rehabilitation via virtual environment in patients suffering from dementia. Psychiatr. Psychiatr. 2018, 29, 42–51. [Google Scholar] [CrossRef]
- Foloppe, D.A.; Richard, P.; Yamaguchi, T.; Etcharry-Bouyx, F.; Allain, P. The potential of virtual reality-based training to enhance the functional autonomy of Alzheimer’s disease patients in cooking activities: A single case study. Neuropsychol. Rehabil. 2018, 28, 709–733. [Google Scholar] [CrossRef]
- Panerai, S.; Gelardi, D.; Catania, V.; Rundo, F.; Tasca, D.; Musso, S.; Prestianni, G.; Muratore, S.; Babiloni, C.; Ferri, R. Functional Living Skills: A Non-Immersive Virtual Reality Training for Individuals with Major Neurocognitive Disorders. Sensors 2021, 21, 5751. [Google Scholar] [CrossRef]
- Folstein, M.F.; Folstein, S.E.; McHugh, P.R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189–198. [Google Scholar]
- Lawton, M.P.; Brodie, E.M. Assessment of older people: Self maintaining and instrumental activity of daily living. J. Gerontol. 1969, 9, 179–186. [Google Scholar]
- Roley, S.S.; DeLany, J.V.; Barrows, C.J.; Brownrigg, S.; Honaker, D.; Sava, D.I.; Talley, V.; Voelkerding, K.; Amini, D.A.; Smith, E.; et al. Occupational therapy practice framework: Domain & practice, 2nd edition. Am. J. Occup. Ther. Off. Publ. Am. Occup. Ther. Assoc. 2008, 62, 625–683. [Google Scholar] [CrossRef]
- Cooper, J.O.; Heron, T.E.; Heward, W.L. Applied Behavior Analysis, 2nd ed.; Pearson Prentice Hall: Upper Saddle River, NJ, USA, 2007. [Google Scholar]
- Panerai, S. Non-pharmacological treatments for people with Major Neurocognitive Disorders: What suggestions from Applied Behavior Analysis? An overview. Life Span Disabil. 2021, XXIV, 237–267. [Google Scholar]
- Morford, Z.H.; Witts, B.N.; Killingsworth, K.J.; Alavosius, M.P. Gamification: The Intersection between Behavior Analysis and Game Design Technologies. Behav. Anal. 2014, 37, 25–40. [Google Scholar] [CrossRef] [PubMed]
- Carnett, A.; Neely, L.; Gardiner, S.; Kirpatrick, M.; Quarles, J.; Christopher, K. Systematic Review of Virtual Reality in Behavioral Interventions for Individuals with Autism. Adv. Neurodev. Disord. 2022. [Google Scholar] [CrossRef]
- Basso, A.; Capitani, E.; Laiacona, M. Raven’s Coloured Progressive Matrices: Normative values on 305 adult normal controls. Funct. Neurol. 1987, 2, 189–194. [Google Scholar]
- Monaco, M.; Costa, A.; Caltagirone, C.; Carlesimo, G.A. Erratum to: Forward and backward span for verbal and visuo-spatial data: Standardization and normative data from an Italian adult population. Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 2015, 36, 345–347. [Google Scholar] [CrossRef]
- Carlesimo, G.A.; Caltagirone, C.; Gainotti, G. The Mental Deterioration Battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur. Neurol. 1996, 36, 378–384. [Google Scholar] [CrossRef]
- Dubois, B.; Slachevsky, A.; Litvan, I.; Pillon, B. The FAB: A Frontal Assessment Battery at bedside. Neurology 2000, 55, 1621–1626. [Google Scholar] [CrossRef]
- Katz, S.; Ford, A.B.; Moskowitz, R.W.; Jackson, B.A.; Jaffe, M.W. Studies of Illness in the Aged. The Index of Adl: A Standardized Measure of Biological and Psychosocial Function. JAMA 1963, 185, 914–919. [Google Scholar] [CrossRef]
- Riva, G.; Mancuso, V.; Cavedoni, S.; Stramba-Badiale, C. Virtual reality in neurorehabilitation: A review of its effects on multiple cognitive domains. Expert Rev. Med. Devices 2020, 17, 1035–1061. [Google Scholar] [CrossRef]
- Chen, X.; Liu, F.; Lin, S.; Yu, L.; Lin, R. Effects of Virtual Reality Rehabilitation Training on Cognitive Function and Activities of Daily Living of Patients with Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis. Arch. Phys. Med. Rehabil. 2022, 103, 1422–1435. [Google Scholar] [CrossRef] [PubMed]
- Oliveira, J.; Gamito, P.; Souto, T.; Conde, R.; Ferreira, M.; Corotnean, T.; Fernandes, A.; Silva, H.; Neto, T. Virtual Reality-Based Cognitive Stimulation on People with Mild to Moderate Dementia due to Alzheimer’s Disease: A Pilot Randomized Controlled Trial. Int. J. Environ. Res. Public Health 2021, 18, 5290. [Google Scholar] [CrossRef] [PubMed]
- Lafosse, J.M.; Reed, B.R.; Mungas, D.; Sterling, S.B.; Wahbeh, H.; Jagust, W.J. Fluency and memory differences between ischemic vascular dementia and Alzheimer’s disease. Neuropsychology 1997, 11, 514–522. [Google Scholar] [CrossRef] [PubMed]
- Hampstead, B.M.; Libon, D.J.; Moelter, S.T.; Swirsky-Sacchetti, T.; Scheffer, L.; Platek, S.M.; Chute, D. Temporal order memory differences in Alzheimer’s disease and vascular dementia. J. Clin. Exp. Neuropsychol. 2010, 32, 645–654. [Google Scholar] [CrossRef]
- Traykov, L.; Baudic, S.; Raoux, N.; Latour, F.; Rieu, D.; Smagghe, A.; Rigaud, A.S. Patterns of memory impairment and perseverative behavior discriminate early Alzheimer’s disease from subcortical vascular dementia. J. Neurol. Sci. 2005, 229–230, 75–79. [Google Scholar] [CrossRef]
- Livner, A.; Laukka, E.J.; Karlsson, S.; Bäckman, L. Prospective and retrospective memory in Alzheimer’s disease and vascular dementia: Similar patterns of impairment. J. Neurol. Sci. 2009, 283, 235–239. [Google Scholar] [CrossRef]
- Ansado, J.; Chasen, C.; Bouchard, S.; Northoff, G. How brain imaging provides predictive biomarkers for therapeutic success in the context of virtual reality cognitive training. Neurosci. Biobehav. Rev. 2021, 120, 583–594. [Google Scholar] [CrossRef]
- Lee, D.H.; Seo, S.W.; Roh, J.H.; Oh, M.; Oh, J.S.; Oh, S.J.; Kim, J.S.; Jeong, Y. Effects of Cognitive Reserve in Alzheimer’s Disease and Cognitively Unimpaired Individuals. Front. Aging Neurosci. 2022, 13, 784054. [Google Scholar] [CrossRef]
- Lesuis, S.L.; Hoeijmakers, L.; Korosi, A.; de Rooij, S.R.; Swaab, D.F.; Kessels, H.W.; Lucassen, P.J.; Krugers, H.J. Vulnerability and resilience to Alzheimer’s disease: Early life conditions modulate neuropathology and determine cognitive reserve. Alzheimers Res. Ther. 2018, 10, 95. [Google Scholar] [CrossRef]
- Mondini, S.; Madella, I.; Zangrossi, A.; Bigolin, A.; Tomasi, C.; Michieletto, M.; Villani, D.; Di Giovanni, G.; Mapelli, D. Cognitive Reserve in Dementia: Implications for Cognitive Training. Front. Aging Neurosci. 2016, 8, 84. [Google Scholar] [CrossRef]
- Kahneman, D. Thinking, Fast and Slow; Farrar, Straus & Giroux: New York, NY, USA, 2011. [Google Scholar]
- Riva, G. Neuroscience of Virtual Reality and Behavioral Change. Available online: https://www.slideshare.net/bepperiva/neuroscience-of-virtual-reality-and-behavioral-change-giuseppe-riva-phd (accessed on 6 August 2021).
- Moreno, A.; Wall, K.J.; Thangavelu, K.; Craven, L.; Ward, E.; Dissanayaka, N.N. A systematic review of the use of virtual reality and its effects on cognition in individuals with neurocognitive disorders. Alzheimer’s Dement. Transl. Res. Clin. Interv. 2019, 5, 834–850. [Google Scholar] [CrossRef] [PubMed]
- Robert, P.H.; Mulin, E.; Malléa, P.; David, R. Review: Apathy diagnosis, assessment, and treatment in Alzheimer’s disease. CNS Neurosci. Ther. 2010, 16, 263–271. [Google Scholar] [CrossRef] [PubMed]
Sample Characteristics | EG Degenerative Conditions | EG Non-Degenerative Conditions | CG Degenerative Conditions | CG Non-Degenerative Conditions | p = |
---|---|---|---|---|---|
Degenerative/non-degenerative conditions, N | 19 | 21 | 17 | 10 | NS a |
M-NCD severity level, N | NS b | ||||
MMSE < 18 | 4 | 3 | 4 | 1 | |
MMSE 18–23 | 13 | 11 | 8 | 6 | |
MMSE >23 | 6 | 13 | 5 | 3 | |
Sex, F/M, N | 13/6 | 12/9 | 13/4 | 5/5 | NS a |
Chronological age, years | 71 (65–77.5) | 65 (55–71) | 69 (62–72) | 59.5 (57.25–61.75) | 0.015 c* |
Education, years | 8 (5–10.5) | 5 (5–8) | 8 (5–13) | 8 (8–11) | NS c |
Use of technological devices | 1 (1–2) | 2 (1–2) | NS d | ||
MMSE, corrected score | 20.42 (18.61–21.69) | 20.29 (19.33–23.14) | 19.86 (16–23.86) | 20.46 (19.97–23.49) | NS c |
CPM, corrected score | 20.5 (16.85–24.25) | 21.2 (18.4–26.2) | 18.9 (15.25–23.75) | 20.5 (20.5–30.5) | NS c |
Corsi’s test, corrected score | 4.51 (3.46–4.66) | 3.88 (3.42–4.36) | 3.57 (3.09–4.11) | 4.07 (3.25–4.15) | NS c |
Digit span, corrected score | 4.65 (4.15–5.13) | 4.34 (3.62–4.65) | 4.13 (3.48–5.08) | 4.18 (4.11–4.64) | NS c |
Rey’s 15 words, immediate recall, corrected score | 26.8 (22.18–28.15) | 26.9 (22.3–30.9) | 20.3 (17.18–28.78) | 25.03 (20.03–28.3) | NS c |
Rey’s 15 words, delayed recall, corrected score | 4.2 (3.15–6.03) | 3.1 (0.7–5.7) | 2.92 (0–5.83) | 2.02 (0.27–6.02) | NS c |
FAB, raw score | 9 (7–12) | 9.5 (8–11) | 11 (6–12) | 10 (8–13) | NS c |
ADL, raw score | 6 (6–6) | 5.5 (4–6) | 5.5 (5–6) | 6 (5–6) | NS c |
IADL, % | 50 (37.5–62.5) | 50 (25–62.5) | 50 (34.38–75) | 80 (63.38–83) | NS c |
Information, correct responses | 24 (21–24.5) | 26 (21–27.25) | 24 (22–26) | 28 (26.25–28.75) | 0.015 c+ |
Information, total time, s | 268 (230–285) | 264.5 (243.5–286.5) | 293.5 (255.5–361.75) | 203 (182.5–225.25) | 0.017 c” |
Suitcase, correct responses | 4 (2–5) | 7 (4–9) | 5 (2–9) | 7.5 (6.25–9) | 0.02 c° |
Suitcase, total time, s | 216 (145–307.5) | 238 (179–369) | 301.5 (198–439.5) | 164 (139–212) | NS c |
Medicines, correct responses | 6 (4–8) | 7 (6–8.5) | 5.5 (2.75–7.25) | 9 (5.75–10) | NS c |
Medicines, total time, s | 178 (167–245) | 227.5 (140.25–321.75) | 236 (164–340) | 219 (108–316) | NS c |
Supermarket, correct responses | 10 (7.5–12) | 13 (8–13) | 11 (5–12.5) | 11 (10–14) | NS c |
Supermarket, total time, s | 260 (203.5–383) | 270 (218–360) | 327.5 (252.25–365.25) | 247 (202–290) | NS c |
In Vivo Tests | 1. EG-DC N = 19 | 2. EG-NDC N = 21 | 3. CG-DG N = 17 | 4. CG-NDC N = 10 | Kruskal–Wallis Test | Post Hoc Test * | |||
---|---|---|---|---|---|---|---|---|---|
1 vs. 2 | 3 vs. 4 | 1 vs. 3 | 2 vs. 4 | ||||||
T3-T1 | T3-T1 | T3-T1 | T3-T1 | p = | z, p = | z, p = | z, p = | z, p = | |
Information correct responses | 3 (2/3.5) ** | 3 (1.75–4.25) ** | 0 (−1/1) | 0 (−0.75/0) | 0.00006 | NS | NS | 3.3 0.00094 | 3.3 0.0096 |
Information total time, s | –38 (–73.5/–19.5) ** | –62.5 (–108.5/–48) ** | −48 (−85/−11) ** | −17.5 (−42.25/0) | NS | ||||
Suitcase correct responses | 3 (0.5–5) ** | 2 (0–4) ** | 0 (−1/1) | 0 (−1.75/−0.75) | 0.0009 | NS | NS | 2.8 0.005 | 2.85 0.004 |
Suitcase total time, s | 6 (–41/67) | –41 (–137/16) | −16 (−103/−4) | −21.5 (−28.75/60.75) | NS | ||||
Medicines correct responses | 2 (0/3) ** | 1 (0.5/2.5) | 0 (0/2) | 0 (0/0) | 0.016 | NS | NS | 2.22 0.03 | 2.29 0.02 |
Medicines total time, s | –39 (–80/–4) | –57 (–91/–22.5) ** | 1.5 (−71.25/27.5) | −8 (−53.5/−3) | NS | ||||
Supermarket correct responses | 2 (1/4) ** | 1 (1/4) ** | 0 (0/1) | 1 (0/1) | 0.037 | NS | NS | 2.6 0.009 | NS |
Supermarket total time, s | 30 (–145/72.5) | –27 (–109/54) | −31 (−61/−2) | −7 (−55.5/3.75) | NS |
Correct Responses | Errors | Missing Responses | Clues | Total Time, s | |
---|---|---|---|---|---|
Non-degenerative conditions | |||||
Information | 0.00001; 0.22 | NS | <0.00001; 0.37 | 0.00001; 0.22 | <0.00001; 0.4 |
Suitcase | <0.00001; 0.39 | NS | <0.00001; 0.38 | <0.00001; 0.37 | <0.00001; 0.54 |
Medicines | 0.00037; 0.18 | NS | <0.00001; 0.25 | 0.00037; 0.18 | <0.00001; 0.46 |
Supermarket | <0.00001; 0.32 | 0.0085; 0.12 | <0.00001; 0.24 | <0.00001; 0.31 | <0.00001; 0.33 |
Degenerative conditions | |||||
Information | 0.00001; 0.0.24 | NS | <0.00001; 0.0.29 | 0.00001; 0.25 | <0.00001; 0.56 |
Suitcase | 0.002; 0.18 | NS | 0.008; 0.15 | 0.0007; 0.15 | 0.00001; 0.28 |
Medicines | 0.03; 0.13 | NS | <0.00001; 0.24 | 0.027; 0.13 | <0.00001; 0.31 |
Supermarket | 0.025; 0.07 | NS | 0.00008; 0.24 | 0.00001; 0.27 | <0.00001; 0.31 |
1st Session | 5th Session | 10th Session | |
---|---|---|---|
Information, correct responses | z = 1.29; p = 0.2 | z = 1.7; p = 0.09 | z = 1.91; p = 0.06 |
Information, missing responses | z = 0.66; p = 0.51 | z = 1.22; p = 0.22 | z = 2.17; p = 0.03; r = 0.35 |
Information, clues | z = −1.3; p = 0.19 | z = −1.67; p = 0.09 | z = −1.91; p = 0.06 |
Information, total time, s | z = 0.04; p = 0.97 | z = 0.87; p = 0.38 | z = 0.91; p = 0.36 |
Suitcase, correct responses | z = 1.04; p = 0.3 | z = 1.18; p = 0.24 | z = 2.09; p = 0.037; r = 0.33 |
Suitcase, missing responses | z = 0.7; p = 0.48 | z = 1.62; p = 0.1 | z = 1.58; p = 0.11 |
Suitcase, clues | z = 0.64; p = 0.52 | z = 0.74; p = 0.46 | z = 1.71; p = 0.09 |
Suitcase, total time, s | z = 0.25; p = 0.8 | z = 0.32; p = 0.75 | z = 1.29; p = 0.19 |
Medicines, correct responses | z = 1.33; p = 0.18 | z = 2.28; p = 0.023; r = 0.37 | z = 0.87; p = 0.38 |
Medicines, missing responses | z = 2.31; p = 0.021; r = 0.37 | z = 1.68; p = 0.093 | z = 1.09; p = 0.28 |
Medicines, clues | z = 1.33; p = 0.18 | z = 2.28; p = 0.023; r = 0.37 | z = 0.87; p = 0.38 |
Medicines, total time, s | z = 0.99; p = 0.32 | z = 0.98; p = 0.33 | z = 0.52; p = 0.6 |
Supermarket, correct responses | z = 1.59; p = 0.11 | z = 2.97; p = 0.003; r = 0.48 | z = 2.12; p = 0.034; r = 0.34 |
Supermarket, missing response | z = 1.55; p = 0.25 | z = 2.04; p = 0.04; r = 0.33 | z = 1.48; p = 0.14 |
Supermarket, clues | z = 1.59; p = 0.11 | z = 1.15; p = 0.25 | z = 1.28; p = 0.2 |
Supermarket, total time, s | z = 0.23; p = 0.8 | z = 0.81; p = 0.42 | z = 1.58; p = 0.11 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Panerai, S.; Catania, V.; Rundo, F.; Tasca, D.; Musso, S.; Babiloni, C.; Prestianni, G.; Muratore, S.; Ferri, R. Functional Living Skills in Patients with Major Neurocognitive Disorder Due to Degenerative or Non-Degenerative Conditions: Effectiveness of a Non-Immersive Virtual Reality Training. Sensors 2023, 23, 1896. https://doi.org/10.3390/s23041896
Panerai S, Catania V, Rundo F, Tasca D, Musso S, Babiloni C, Prestianni G, Muratore S, Ferri R. Functional Living Skills in Patients with Major Neurocognitive Disorder Due to Degenerative or Non-Degenerative Conditions: Effectiveness of a Non-Immersive Virtual Reality Training. Sensors. 2023; 23(4):1896. https://doi.org/10.3390/s23041896
Chicago/Turabian StylePanerai, Simonetta, Valentina Catania, Francesco Rundo, Domenica Tasca, Sabrina Musso, Claudio Babiloni, Giuseppina Prestianni, Stefano Muratore, and Raffaele Ferri. 2023. "Functional Living Skills in Patients with Major Neurocognitive Disorder Due to Degenerative or Non-Degenerative Conditions: Effectiveness of a Non-Immersive Virtual Reality Training" Sensors 23, no. 4: 1896. https://doi.org/10.3390/s23041896
APA StylePanerai, S., Catania, V., Rundo, F., Tasca, D., Musso, S., Babiloni, C., Prestianni, G., Muratore, S., & Ferri, R. (2023). Functional Living Skills in Patients with Major Neurocognitive Disorder Due to Degenerative or Non-Degenerative Conditions: Effectiveness of a Non-Immersive Virtual Reality Training. Sensors, 23(4), 1896. https://doi.org/10.3390/s23041896